Ocean Biomedical, Inc. Research And Development Expense

• Ocean Biomedical, Inc. showed a decrease of -96.3% in Research And Development Expense from 2023 to 2024.
• This data is from Ocean Biomedical, Inc.'s annual report (Form 10-K), filed with the SEC on April 8, 2025.
• XBRL data for this metric is available from 2022 to 2024 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2022: $3.20 million | Q2 2022: $3.19 million | Q3 2022: $1.86 million | Q1 2023: $393.0 thousand | Q2 2023: $28.0 thousand | Q3 2023: $305.0 thousand | Q1 2024: $26.0 thousand | Q1 2025: $18.0 thousand.
• Over the full 3 years of available data (2022 to 2024), Ocean Biomedical, Inc.'s Research And Development Expense has declined by 99.7%.
• Historical annual values: Fiscal year 2024: $26.0 thousand | Fiscal year 2023: $709.0 thousand | Fiscal year 2022: $8.41 million.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026